Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.059 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |